These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8892090)

  • 21. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
    Wyss-Coray T; Brander C; Frutig K; Pichler WJ
    Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T lymphotropic virus type I.
    Inatsuki A; Yasukawa M; Kobayashi Y
    J Immunol; 1989 Aug; 143(4):1327-33. PubMed ID: 2473128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
    Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
    J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells.
    Nishioka C; Ikezoe T; Yang J; Udaka K; Yokoyama A
    Immunology; 2013 Mar; 138(3):216-27. PubMed ID: 23278479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant.
    Kozako T; Hirata S; Shimizu Y; Satoh Y; Yoshimitsu M; White Y; Lemonnier F; Shimeno H; Soeda S; Arima N
    FEBS J; 2011 Apr; 278(8):1358-66. PubMed ID: 21332943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
    Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
    J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation.
    Mostoller K; Norbury CC; Jain P; Wigdahl B
    J Neurovirol; 2004 Dec; 10(6):358-71. PubMed ID: 15765807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation--characterization of membrane TNF-alpha.
    Higuchi M; Nagasawa K; Horiuchi T; Oike M; Ito Y; Yasukawa M; Niho Y
    Clin Immunol Immunopathol; 1997 Feb; 82(2):133-40. PubMed ID: 9000481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor-mediated signal transduction in transformed human T-cells.
    Arimilli S; Nag B
    Recept Signal Transduct; 1997; 7(3):151-63. PubMed ID: 9440502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonactivated astrocytes downregulate T cell receptor expression and reduce antigen-specific proliferation and cytokine production of myelin basic protein (MBP)-reactive T cells.
    Sun D; Coleclough C; Whitaker JN
    J Neuroimmunol; 1997 Sep; 78(1-2):69-78. PubMed ID: 9307229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
    Kannagi M; Matsushita S; Shida H; Harada S
    Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
    Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
    Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
    J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
    Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
    Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of T-cell functions by infection with HTLV-I or HTLV-II.
    Popovic M; Flomenberg N; Volkman DJ; Mann D; Fauci AS; Dupont B; Gallo RC
    Science; 1984 Oct; 226(4673):459-62. PubMed ID: 6093248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
    Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.